Literature DB >> 33531622

Increased functional coupling of the mu opioid receptor in the anterior insula of depressed individuals.

Pierre-Eric Lutz1,2, Daniel Almeida3, Dominique Filliol4, Fabrice Jollant3,5,6,7, Brigitte L Kieffer4,8,9, Gustavo Turecki10.   

Abstract

The mu opioid receptor (MOR) is a G protein-coupled receptor that plays an essential role in reward and hedonic processes, and that has been implicated in disorders such as depression and addiction. Over the last decade, several brain imaging studies in depressed patients have consistently found that dysregulation of MOR function occurs in particular in the anterior insular cortex, an important brain site for the perception of internal states and emotional regulation. To investigate molecular mechanisms that may underlie these effects, here we assessed genetic polymorphisms, expression, and functional G-protein coupling of MOR in a large post-mortem cohort (N = 95) composed of depressed individuals who died by suicide, and healthy controls. Results indicated that depression, but not comorbid substance use disorder or acute opiate consumption, was associated with increased MOR activity. This effect was partly explained by a specific increase in expression of the inhibitory alpha G-protein subunit GNAI2. Consistent with previous neuroimaging studies, our findings support the notion that enhanced endogenous opioidergic tone in the anterior insula may buffer negative affective states in depressed individuals, a mechanism that could potentially contribute to the antidepressant efficacy of emerging opioid-based medications.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33531622      PMCID: PMC8115105          DOI: 10.1038/s41386-021-00974-y

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  43 in total

Review 1.  The Insula: An Underestimated Brain Area in Clinical Neuroscience, Psychiatry, and Neurology.

Authors:  Ho Namkung; Sun-Hong Kim; Akira Sawa
Journal:  Trends Neurosci       Date:  2017-03-15       Impact factor: 13.837

2.  Postmortem mu-opioid receptor binding in suicide victims and controls.

Authors:  G Zalsman; A Molcho; Y Huang; A Dwork; S Li; J J Mann
Journal:  J Neural Transm (Vienna)       Date:  2004-11-24       Impact factor: 3.575

3.  Regional mu opioid receptor regulation of sensory and affective dimensions of pain.

Authors:  J K Zubieta; Y R Smith; J A Bueller; Y Xu; M R Kilbourn; D M Jewett; C R Meyer; R A Koeppe; C S Stohler
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

4.  mu-opioid receptor and alpha2-adrenoceptor agonist stimulation of [35S]GTPgammaS binding to G-proteins in postmortem brains of opioid addicts.

Authors:  J J Meana; J González-Maeso; J A García-Sevilla; J Guimón
Journal:  Mol Psychiatry       Date:  2000-05       Impact factor: 15.992

5.  Striatal Dopamine Release in Response to Morphine: A [11C]Raclopride Positron Emission Tomography Study in Healthy Men.

Authors:  Primavera A Spagnolo; Alane Kimes; Melanie L Schwandt; Ehsan Shokri-Kojori; Shantalaxmi Thada; Karran A Phillips; Nancy Diazgranados; Kenzie L Preston; Peter Herscovitch; Dardo Tomasi; Vijay A Ramchandani; Markus Heilig
Journal:  Biol Psychiatry       Date:  2019-03-15       Impact factor: 13.382

6.  Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women.

Authors:  Susan E Kennedy; Robert A Koeppe; Elizabeth A Young; Jon-Kar Zubieta
Journal:  Arch Gen Psychiatry       Date:  2006-11

7.  It still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder.

Authors:  D T Hsu; B J Sanford; K K Meyers; T M Love; K E Hazlett; S J Walker; B J Mickey; R A Koeppe; S A Langenecker; J-K Zubieta
Journal:  Mol Psychiatry       Date:  2015-01-20       Impact factor: 15.992

Review 8.  Opioid receptors: distinct roles in mood disorders.

Authors:  Pierre-Eric Lutz; Brigitte L Kieffer
Journal:  Trends Neurosci       Date:  2012-12-06       Impact factor: 13.837

9.  Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission.

Authors:  Jon-Kar Zubieta; Terence A Ketter; Joshua A Bueller; Yanjun Xu; Michael R Kilbourn; Elizabeth A Young; Robert A Koeppe
Journal:  Arch Gen Psychiatry       Date:  2003-11

10.  Response of the μ-opioid system to social rejection and acceptance.

Authors:  D T Hsu; B J Sanford; K K Meyers; T M Love; K E Hazlett; H Wang; L Ni; S J Walker; B J Mickey; S T Korycinski; R A Koeppe; J K Crocker; S A Langenecker; J-K Zubieta
Journal:  Mol Psychiatry       Date:  2013-08-20       Impact factor: 15.992

View more
  3 in total

1.  Insula network connectivity mediates the association between childhood maltreatment and depressive symptoms in major depressive disorder patients.

Authors:  Cancan He; Dandan Fan; Xinyi Liu; Qing Wang; Haisan Zhang; Hongxing Zhang; Zhijun Zhang; Chunming Xie
Journal:  Transl Psychiatry       Date:  2022-03-02       Impact factor: 6.222

2.  Convergence of case-specific epigenetic alterations identify a confluence of genetic vulnerabilities tied to opioid overdose.

Authors:  Olivia Corradin; Richard Sallari; An T Hoang; Bibi S Kassim; Gabriella Ben Hutta; Lizette Cuoto; Bryan C Quach; Katreya Lovrenert; Cameron Hays; Berkley E Gryder; Marina Iskhakova; Hannah Cates; Yanwei Song; Cynthia F Bartels; Dana B Hancock; Deborah C Mash; Eric O Johnson; Schahram Akbarian; Peter C Scacheri
Journal:  Mol Psychiatry       Date:  2022-03-17       Impact factor: 13.437

Review 3.  Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rationale, Successes, and Future Needs.

Authors:  Andrew Lofts; Fahed Abu-Hijleh; Nicolette Rigg; Ram K Mishra; Todd Hoare
Journal:  CNS Drugs       Date:  2022-06-27       Impact factor: 6.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.